Insider trade

Lisa Egbuonu-davis, Director at Omega Healthcare Investors, sold ~$92K of Omega Healthcare Investors shares.

~$92K
Approx. value · 2,300 sh @ $40.16
19K
Holds after · shares reported
Traded
Aug 8, 2025
Filed
Aug 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 8, 2025 · this disclosureInsiderDirector sold ~$92K of OHI shares in the open market

What came next

  1. Aug 8, 2025InsiderDirector sold ~$8K of OHI shares in the open market
  2. Sep 30, 2025Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 2 more items)
  3. Oct 15, 2025Company filing · Form 8-K · Agreement endedEnded an important agreement
  4. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Omega Healthcare Investors

For Omega Healthcare Investors, OQRO holds 5 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OHI page.

Other recent filings by Lisa Egbuonu-davis, Director

The full history of Lisa Egbuonu-davis, Director is on the profile page.

How this filing works

Other disclosures at Omega Healthcare Investors

Everything OQRO holds on this company is on its OHI page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data